Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:administeredBy |
injection
|
| gptkbp:affiliatedWith |
aminoglycoside antibiotics
|
| gptkbp:approvedBy |
gptkb:FDA
1975 |
| gptkbp:ATCCode |
gptkb:J01GB01
|
| gptkbp:contraindication |
hypersensitivity to tobramycin
|
| gptkbp:discoveredIn |
1967
|
| gptkbp:genericName |
gptkb:tobramycin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nebcin
|
| gptkbp:indication |
severe infections caused by Gram-negative bacteria
|
| gptkbp:marketedAs |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
nephrotoxicity
ototoxicity |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:tobramycin
|
| gptkbp:bfsLayer |
6
|